1887
  1. Home
  2. BSAVA Small Animal Formulary Part A: Canine and Feline
  3. Velagliflozin
Velagliflozin
; https://doi.org/
/content/dataitem/canine-and-feline/velagliflozin

Velagliflozin

Online Access: Subscribe
This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition. 
  1. Behrend EN, Ward CR, Chukwu V et al. (2024) Velagliflozin, a once-daily, liquid, oral SGLT2 inhibitor, is effective as a stand-alone therapy for feline diabetes mellitus: the SENSATION study. Journal of the American Veterinary Medical Association 262, 1343–1353
    2.
  2. Hoenig M, Clark M, Schaeffer DJ and Reiche D (2018) Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats. Journal of Veterinary Pharmacology and Therapeutics 41, 266–273
    3.
  3. Niessen SJM, Voth R, Kroh C and Hennings L (2023) Once daily oral therapy for feline diabetes mellitus: SGLT-2-inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats. In: Research Communications of the 32nd ECVIM-CA Online Congress. Journal of Veterinary Internal Medicine 36, 2512–2513
    4.
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error